Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Figure 1

1A. Pre- (dark bars) and post-hydralazine treatment (light bars). The bars represent the number of patients that showed methylation for each studied gene from each of the 16 patients. 1B. Representative cases of genes (M methylated, U unmethylated; pre/post): M/M; M/U; U/U, M/U; MU/U; M/ U-M. 1C. Percentage of demethylation after treatment according to the dose. Percentage was calculated considering 100% methylation the total number of pre-treatment methylated genes in each cohort of 4 patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us